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In SH-SY5Y human neuroblastoma cells, the cholinergic agonist, carbachol, stimulates
phosphorylation of the small heat shock protein 27 (HSP27). Carbachol increases phosphorylation
of both Ser-82 and Ser-78 while the phorbol ester, phorbol-12, 13-dibutyrate (PDB) affects only
Ser-82. Muscarinic receptor activation by carbachol was confirmed by sensitivity of Ser-82
phosphorylation to hyoscyamine with no effect of nicotine or bradykinin. This response to
carbachol is partially reduced by inhibition of protein kinase C (PKC) with GF 109203X and p38
mitogen-activated protein kinase (MAPK) with SB 203580. In contrast, phosphorylation produced
by PDB is completely reversed by GF 109203X or CID 755673, an inhibitor of PKD. Inhibition of
phosphatidylinositol 3-kinase or Akt with LY 294002 or Akti-1/2 stimulates HSP27
phosphorylation while rapamycin, which inhibits mTORC1, does not. The stimulatory effect of
Akti-1/2 is reversed by SB 203580 and correlates with increased p38 MAPK phosphorylation. SHSY5Y cells differentiated with a low concentration of PDB and basic fibroblast growth factor to a
more neuronal phenotype retain carbachol-, PDB- and Akti-1/2-responsive HSP27
phosphorylation. Immunofluorescence microscopy confirms increased HSP27 phosphorylation in
response to carbachol or PDB. At cell margins, PDB causes f-actin to reorganize forming
lamellipodial structures from which phospho-HSP27 is segregated. The resultant phenotypic
change in cell morphology is dependent upon PKC, but not PKD, activity. The major conclusion
from this study is that the phosphorylated state of HSP27 in SH-SY5Y cells results from
integrated signaling involving PKC, p38 MAPK and Akt.

1. Introduction
The small heat shock protein, HSP27 (HSPB1), promotes neuronal survival (Latchman,
2005), a function well characterized in sensory neurons (Lewis et al., 1999; Dodge et al.,
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2006). In brain, HSP27 is induced by heat shock and other insults (Akbar et al., 2001;
Bechtold and Brown, 2003) and is neuroprotective in experimental models of epilepsy,
stroke and amyotrophic lateral sclerosis in vivo (Akbar et al., 2003; Badin et al., 2006; Sharp
et al., 2008). Both constitutive and induced levels of HSP27 may limit neuronal
vulnerability to neurodegenerative states (Klettner, 2004; Chen and Brown, 2007). For
example, HSP27 associates with plaques and tangles in the Alzheimer’s disease brain and
protects against β-amyloid- or phosphorylated tau-induced cell pathology (Shimura et al.,
2004; King et al., 2009; Koren et al., 2009).
Signal transduction pathways regulate the phosphorylated state of HSP27 at three major
sites (Ser-15, Ser-78 and Ser-82 in the human sequence) through the activities of sequential
protein kinases, principally p38 mitogen-activated protein kinase (MAPK)/MAPK-activated
protein kinase-2 (MAPKAPK-2; also termed MK2) and protein kinase C (PKC)/protein
kinase D (PKD) (Kostenko and Moens, 2009). Although anti-apoptotic and adaptive
functions of HSP27 depend upon its phosphorylated state (Lavoie et al., 1993 and 1995;
Rogalla et al., 1999; Benn et al., 2002; Geum et al., 2002), relatively little is known
regarding factors that modulate HSP27 phosphorylation once it is expressed in neurons.
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The SH-SY5Y cell line is an N-type neuroblastoma that can be differentiated to a more
physiological phenotype while expressing endogenous HSP27 and muscarinic receptors,
predominantly the M3 subtype (Lambert et al., 1989; Lavenius et al., 1994). M3 receptors on
various cell lines activate PKC, extracellular signal-regulated protein kinase 1/2 (ERK1/2),
phosphatidylinositol 3-kinase (PI3-K) and Akt (Slack, 2000; Tang et al., 2002; Anger et al.,
2007; Rosethorne et al., 2008). Signal transduction pathways involving these protein kinases
regulate gene expression and cytoskeletal dynamics in SH-SY5Y cells while activation of
Gq/11 receptors on these cells broadly protects against apoptosis induced by diverse injurious
stimuli (Rösner et al., 1995; DeSarno et al., 2003; Mookherjee et al., 2007; Rössler et al.,
2008). Such end points are also modulated by HSP27 (Landry and Huot, 1999; Benn and
Wolf, 2004). A precedent for muscarinic receptor-coupled HSP27 phosphorylation exists in
smooth muscle where it induces association of contractile proteins and PKC with elements
of the cytoskeleton (Reviewed in Gerthoffer, 2005).
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As part of its anti-apoptotic and chaperone functions, HSP27 stabilizes the actin-based
cytoskeleton during periods of stress (Lavoie et al, 1995; Geum et al., 2002; Landry and
Huot, 1999) and modulates actin filament dynamics related to cell structure and motility
(Lavoie et al., 1993; During et al., 2007). In SH-SY5Y cells, cholinergic receptor
stimulation or a phorbol ester cause rapid reorganization of the actin-based cytoskeleton in a
PKC-dependent manner that may mediate cell motility and/or secretion of catecholamine
from dense-cored vesicles (Rösner et al., 1995; Viviani et al., 1996; Danks et al., 1999).
Therefore, in the SH-SY5Y neuroblastoma model system, the signal transduction pathways
initiated by muscarinic receptor activation or the phorbol ester, phorbol-12, 13-dibutyrate
(PDB) have been compared with three principal goals: 1.) To characterize phosphorylation
of endogenous HSP27 as it is coupled to muscarinic receptor activation before and after
differentiation with a phorbol ester and growth factor; 2.) To identify the protein kinases
involved in phosphorylation of HSP27, principally at Ser-82, a site critical for the
protein:protein interactions that mediate its functions (Lambert et al., 1999); and 3.) To
determine whether HSP27 phosphorylation correlates with a functional response, i.e.,
reorganization of the actin-based cytoskeleton.
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2.1 Materials
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Dulbecco’s Modification of Eagle’s Medium (DMEM), 1X with 4.5 g/L of glucose, 584 mg/
L of l-glutamine and 110 mg/L of sodium pyruvate, was obtained from Mediatech Inc.,
Herndon, VA, USA. Premium 0.1 µm-filtered fetal bovine serum (FBS) was a product of
Atlanta Biologicals, Atlanta, GA, USA. Penicillin (10,000U/mL)/streptomycin (10,000 µg/
mL), trypsin/EDTA (1X, 0.05%), recombinant human basic fibroblast growth factor (bFGF)
and rhodamine phalloidin were purchased from Invitrogen, Carlsbad, CA, USA.
Hyoscyamine and Triton X-100 were obtained from Sigma-Aldrich Corp., St, Louis, MO,
USA. All protein kinase modulators, nicotine ditartrate and bradykinin were products of
EMD Biosciences (Calbiochem), LaJolla, CA, USA, with the exception of CID 755673 that
was from Tocris Bioscience, Ellisville MO, USA. Anti-rabbit and anti-mouse alkaline
phosphatase-conjugated secondary antibodies and Passive Lysis Buffer (PLB; supplied as a
5X concentrated stock and diluted just before use) were from Promega Corporation,
Madison, WI, USA. Bovine serum albumin (BSA), carbamoylcholine chloride (carbachol,
CCh), dimethyl sulfoxide (DMSO), sorbitol and the anti-phospho-(Ser-85) and -(Ser-15)
primary antibodies used for immunoblotting and immunofluorescence microscopy were
purchased from Fisher Scientific, Waltham MA. (Note that Ser-85 in the sequence of rat
HSP27 corresponds to Ser-82 in the human sequence.). The anti-phospho-(Ser78) primary
antibody was a product of Epitomics, Inc., Burlingame, CA. Phospho-specific primary
antibodies to ERK1/2 (Thr-202/Tyr-204), p38 MAPK (Thr-180/Tyr-182), Akt (Ser-473) and
S6 ribosomal protein (Ser235/236) were products of Cell Signaling Technology, Inc.,
Danvers, MA, USA, as were pan-antibodies to total ERK1/2, p38 MAPK and Akt. Total
HSP27 was detected with a primary antibody from Enzo Life Sciences, Plymouth Meeting,
PA, USA. Polyvinylidene fluoride (PVDF) membrane and preimmune rabbit IgG were
products of Millipore Corp., Inc, Billerica, MA, USA. Fluorescein-conjugated anti-rabbit
IgG (H + L) and Vectashield Hard Set™ Mounting Medium with DAPI (4',6-diamidino-2phenylindole) were purchased from Vector Laboratories, Burlingame CA, USA.
Paraformaldehyde was obtained from Electron Microscopy Services, Hatfield PA, USA, as a
16% aqueous solution.
2.2 Culture and treatment of cells
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The SH-SY5Y cell line (ATCC #CRL-2266™) is a N-type human neuroblastoma derived
from a metastatic bone tumor that expresses muscarinic cholinergic receptors, principally
the M3 subtype (Ross et al., 1983; Lambert et al., 1989). Cells were maintained in
DMEM-10% FBS-50U/mL of penicillin/50 µg/mL of streptomycin and subpassaged at
weekly intervals with change of the medium every 3–4 days. Prior to an experiment, cells
were plated at a density of 8 × 105 cells per uncoated 60 mm polystyrene plate. After 2 days
in culture, the medium was replaced with serum-free DMEM without penicillin/
streptomycin for 60 min prior to the start of an experiment. Hyoscyamine (the active
enantiomer of atropine) or protein kinase inhibitors, as specified in Table I, were added at
the beginning of this preincubation. The time of incubation with CCh and its concentration
were as indicated in specific experiments. Hyoscyamine and CCh were dissolved in DMEM
and an equal volume of medium was added to control plates. Protein kinase modulators and
PDB were solubilized in DMSO. The effects of PDB were analyzed under two conditions:
after addition for the last 15 min of the preincubation at a concentration of 1 µM or for 2 hr
after the end of the preincubation at a concentration of 10 nM. A comparable volume of
DMSO was added to control incubations. In all cases, the concentration of DMSO in the
incubations was less than 0.5%. Basal phosphorylation was defined as that measured in
control incubations containing equal volumes of the DMEM and/or DMSO vehicles. For
imaging with phase contrast microscopy, cells were cultured at a lower density (4 × 105 per
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60 mm polystyrene plate) for two days. The medium was replaced with serum-free DMEM
for 60 min with or without protein kinase inhibitors prior to addition of PDB or DMSO
vehicle as described above.
The effect of hyperosmotic stress on HSP27 phosphorylation was determined by
preincubating cells in serum-free DMEM for 30 min. At this time, medium was replaced
with fresh serum-free DMEM (control) or serum-free DMEM containing 0.3M sorbitol to
produce hyperosmotic conditions and the incubation was continued for an additional 30 min
before preparation of cell lysates. When added in such experiments, SB 203580 was
maintained at a concentration of 10 µM through both phases of the 60 min incubation.
The protocol of Lavenius et al. (1994) was used to differentiate SH-SY5Y cells to a mature
neuronal phenotype. Cells were plated at a density of 1 § 105 cells per well of a 6-well plate
in 2 ml of DMEM-10% FBS-penicillin/streptomycin. After 24 hr, the medium was changed
to serum-free DMEM and PDB and bFGF were added to final concentrations of 16 nM and
3 nM, respectively. Cells were grown under these conditions for 5 days with one change of
medium and PDB/bFGF. Experiments were initiated by replacement of serum-free DMEM
and addition of hyoscyamine, protein kinase inhibitors, CCh and PDB as specified in the
text.
2.3 Protein analysis
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Cell lysates were prepared using 1X PLB according to the manufacturer’s specifications and
stored at −20 °C prior to immunoblotting. Samples containing equal amounts of protein
were resolved with SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were
transferred to PVDF membrane. A 20 min transfer was used in the case of HSP27, a 30 min
transfer for ERK1/2 or p38 MAPK and a 45 min transfer for Akt, based on the relative sizes
of the proteins. Following blocking of nonspecific binding sites with a solution of 2.5% dry
milk-0.1% Tween-20, immunoblotting for phosphorylated proteins was performed with
primary antibodies that recognize the following phosphorylation sites: HSP27, Ser-15,
Ser-78 or Ser-82; ERK1/2, Thr-202/Tyr-204, p38 MAPK, Thr-180/Tyr-182, Akt, Ser-473
and S6 ribosomal protein, Ser-235/236 or with pan antibodies that recognize all isoforms of
each protein. In this paper, any reference to phospho-HSP27 implies phosphorylation of
Ser-82 unless otherwise stated. Immunoreactive bands were visualized using anti-rabbit or
anti-mouse alkaline phosphatase-conjugated secondary antibodies. Equal loading of protein
across all sample lanes of each gel was confirmed by staining the high molecular weight
proteins remaining on gels after transfer to immunoblots.
2.4 Cell Imaging
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To examine morphology, cells were imaged digitally using phase contrast microscopy at
20X magnification with a polarizing filter on a Zeiss Axovert 25CFL fluorescence
microscope. To quantify effects of PDB ± protein kinase inhibitors on cell morphology, 50
cells per field were counted for the presence of lamellipodial profiles. A total of four fields
from duplicate experiments were analyzed under each condition and results were expressed
as the % of cells displaying lamellipodia.
For immunofluorescence microscopy, 5 × 104 cells were cultured on a glass cover slip per
sample for two days. Following replacement of medium with serum-free DMEM for 60 min,
CCh was added at a concentration of 1 mM for 5 min. Incubations with PDB were
performed with a concentration of 1 µM for 15 min. Control samples contained equivalent
volumes of DMEM or DMSO. At the end of the experimental treatments, cells were rinsed
one time with PBS and fixed for 30 min with freshly prepared 4% paraformaldehyde in
PBS. Following two washes with PBS for 5 min, cells were permeabilized in PBS-5%
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BSA-0.2% Triton X-100. Cells were washed three times in PBS prior to addition of
rhodamine phalloidin to a final concentration of 100 nM in PBS-2% BSA-0.2% Triton
X-100 for 30 min to label filamentous (f)-actin. Cells were washed again three times with
PBS. Excess PBS was blotted off the edge of the coverslips and they were sealed to
microscope slides with Vectashield/DAPI.
For immunolabeling, a phospho-specific primary antibody directed against Ser-82 or an
equivalent amount of rabbit preimmune IgG were added at a 1:500 dilution in
PBS-5%BSA-0.2% Triton X-100 following the post-permeabilization washes. Samples were
kept at 4 °C overnight. The next day, cells were washed three times with PBS. An anti-rabbit
IgG secondary antibody conjugated to fluorescein was added for 60 min. Cells were washed
three final times with PBS and adhered to microscope slides with Vectashield/DAPI. For
double-labeling, the antibody incubations were performed after labeling of cells with
rhodamine phalloidin. Images were captured with Metamorph version 7.0 software on a
Nikon Ti-U microscope coupled with Photometrics Coolsnap ES2, 12 bit, 20 MHz Digital
Monochrome Camera with IEEE-1394 interface. All images within one set were taken with
the same exposure time and binning values.
2.5 Quantification and statistical analysis
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Quantification of immunoreactivity on blots was obtained with densitometric analysis of
protein bands using UN-SCAN-IT gel™ digitizing software (Version 6.1, Silk Scientific
Corporation Inc., Orem UT, USA). In all cases, effects on phosphorylation were normalized
to the total amount of each protein determined by immunoblotting with an antibody that
recognizes both phospho- and dephospho-forms. Data are expressed as the mean ± SEM of
results combined from each set of experiments. Statistical analysis was performed using
Student’s T-test with significance defined as p ≤ 0.05.

3. Results
3.1 Activation of muscarinic receptors on SH-SY5Y cells increases HSP27 phosphorylation
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Incubation of SH-SY5Y neuroblastoma cells with 1 mM CCh caused an increase in the
phosphorylation of endogenous HSP27 as detected by immunoblotting with a phosphospecific antibody to Ser-82 (A representative immunoblot is shown in Fig. 1A).
Phosphorylation of this site was analyzed since it regulates the oligomeric state of HSP27, a
critical determinant of its functions (Lambert et al., 1999). Since there was no significant
change in the total amount of HSP27 in the same cell lysates using a primary antibody that
recognizes both phospho- and dephospho-forms of the protein, changes in phosphorylation
of HSP27 were quantified as the ratio of phospho-HSP27 to total HSP27 following
densitometry of immunoreactive bands. At 1–5 min of incubation with 1 mM CCh, a
maximal increase in HSP27 phosphorylation was observed. Thereafter, phosphorylation of
HSP27 declined but remained significantly elevated above basal levels for as long as 60 min
of incubation with CCh (Fig. 1B). The effect of CCh was concentration-dependent with an
EC50 value of approximately 10 µM (pEC50, 4.97 ± 0.02) and a maximal response was
obtained between 0.1 and 1 mM (Fig. 1C). For all further experiments in this study, 1 mM
CCh was used in a 5 min incubation with SH-SY5Y cells.
Involvement of muscarinic receptors in stimulation of HSP27 phosphorylation was
confirmed through use of hyoscyamine, the active enantiomer of atropine. Preincubation of
SH-SY5Y cells for 60 min with a 1 µM concentration of this muscarinic receptor antagonist
had no significant effect on basal phosphorylation of HSP27, but reduced CCh-stimulated
phosphorylation to a level that was not significantly different from basal values (Fig. 2A).
Incubation with 1 mM nicotine for 1 or 5 min had no stimulatory effect on HSP27
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phosphorylation. Specificity of the CCh effect was indicated since bradykinin, another
agonist that activates Gq/11-coupled receptors on SH-SY5Y cells (Rosethorne et al., 2008)
also did not increase HSP27 phosphorylation significantly above basal levels (Fig. 2B).
3.2 Involvement of p38 MAPK and PKC in HSP27 phosphorylation
Activation of the p38 MAPK/MAPKAPK-2 pathway is a well-characterized mechanism for
the phosphorylation of HSP27 at Ser-82. In addition, PKC, which is activated by Gq/11coupled receptors, phosphorylates HSP27 at this site either directly or through p38 MAPK
and/or PKD (Kostenko and Moens, 2009). Therefore, the effects of inhibitors of these
protein kinases on the phosphorylation of HSP27 were determined in SH-SY5Y cells (Fig.
3A). Note that in these and all other experiments that used protein kinase inhibitors,
concentrations of these compounds were chosen with careful attention to the literature so as
to achieve selective inhibition of the target protein kinase in cultured cells (Table I). Cells
were preincubated with the p38 MAPK inhibitor, SB 203580 (10 µM), or the PKC inhibitor,
GF 109203X (5 µM) for 60 min prior to the addition of CCh for 5 min. Neither inhibitor had
a significant effect on basal HSP27 phosphorylation, alone or in combination. Preincubation
with either SB 203580 or GF 109203X had small inhibitory effects on CCh-stimulated
phosphorylation of HSP27 at Ser-82. When the two protein kinase inhibitors were
combined, in the presence of CCh they produced an additive and statistically significant
inhibition of HSP27 phosphorylation, although not to basal levels.
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Lack of a prominent involvement of p38 MAPK or PKC in CCh-mediated HSP27
phosphorylation was in contrast to its phosphorylation in response to other stimuli. When
SH-SY5Y cells were incubated with the phorbol ester, PDB, a known activator of PKC, at a
concentration of 1 µM for 15 min, HSP27 phosphorylation was completely sensitive to GF
109203X (Fig. 3B). Hyperosmotic stress is the prototypical stimulus that activates the
p38MAPK/MAPKAPK-2 pathway (Sheik-hamad and Gustin, 2004). Exposure of SH-SY5Y
cells to hyperosmotic conditions, produced by addition of 0.3M sorbitol to the incubation
medium for 30 min, elicited increased phosphorylation of HSP27 that was nearly completely
reversed by the p38 MAPK inhibitor, SB 203580. These positive controls indicate that the
protein kinase inhibitors were active against appropriate kinase targets at the concentrations
employed in the experiments with CCh. In a more general sense, they demonstrate that
HSP27 phosphorylation at Ser-82 is sensitive to multiple stimuli.
3.3 Comparison of muscarinic receptor-and PDB-mediated HSP27 phosphorylation

NIH-PA Author Manuscript

Since CCh stimulates phosphorylation of HSP27 through muscarinic receptors coupled to
multiple protein kinases while PDB directly activates only PKC, it was of interest to
compare these stimuli with regard to the properties of HSP27 phosphorylation. Analysis of
HSP27 phosphorylation was extended to include the three major phosphorylation sites in
this protein. SH-SY5Y cells were incubated with either CCh or PDB, after which cell lysates
were prepared and immunoblotted with phospho-specific antibodies to Ser-15, Ser-78 and
Ser-82. When normalized to the amount of total HSP27 in lysates, different patterns of
phosphorylation were seen in response to the two stimuli (Fig. 4A): CCh increased
phosphorylation at Ser-78 and Ser-82 to an equal extent while PDB was effective only in
stimulating phosphorylation of Ser-82. Neither CCh nor PDB increased the phosphorylation
of Ser-15 (Fig. 4B).
Although the sole action of a phorbol ester such as PDB is the activation of PKC, both p38
MAPK and/or PKD are reported to be downstream intermediates of PKC signaling in the
phosphorylation of HSP27 at Ser-82 (Takai et al, 2007; Yuan and Rozengurt, 2008).
Therefore, the abilities of a p38 MAPK inhibitor (SB 203580) and a PKD inhibitor (CID
755673) to inhibit PDB-induced phosphorylation of HSP27 were compared. As shown in
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Fig. 4C, the former had no effect on stimulation of HSP27 phosphorylation produced by 1
µM PDB. Incubation of cells with CID 755673, however, inhibited the effect of PDB to an
extent equal to that produced by inhibition of PKC with GF 109203X. CID 755673 had no
effect on basal HSP27 phosphorylation (data not shown). Thus, the predominant pathway
mediating PDB-induced phosphorylation of HSP27 at Ser-82 in SH-SY5Y cells appears to
be from PKC through PKD.
3.4 The PI3-K pathway modulates HSP27 phosphorylation
Since the combination of GF 109203X and SB 203580 only reduced CCh-stimulated HSP27
phosphorylation by approximately 50%, the involvement of an additional protein kinase is
implied. Since exposure of SH-SY5Y cells to CCh increased the phosphorylation of ERK1/2
and Akt at sites linked to activation of these protein kinases (Figs. 5A and B), the effects of
inhibitors of the ERK1/2 and PI3-K pathways on muscarinic receptor-mediated
phosphorylation of HSP27 were compared. The MAP kinase kinase (MKK) inhibitor, PD
98059, did not alter CCh-stimulated HSP27 phosphorylation at 10 µM (Fig. 5C), a
concentration that blocks insulinlike growth factor-1-dependent phosphorylation of ERK2
and neurite outgrowth in SH-SY5Y cells (Kim et al., 1997). The involvement of ERK1/2 in
HSP27 phosphorylation was therefore eliminated from further consideration in this study. In
contrast, the PI3-K pathway was related to muscarinic receptor-activated HSP27
phosphorylation in a complex manner.
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Cells were incubated with inhibitors of three major protein kinases that are sequential
components of the PI3-K pathway: LY 294002 (PI3-K), Akti-1/2 (Akt isoforms 1 and 2),
and rapamycin, [mammalian target of rapamycin complex (mTORC)1]. The expectation was
that if any of these protein kinases were involved in phosphorylation of HSP27 at Ser-82,
the respective inhibitor of that enzyme would block the effect of CCh. Paradoxically, 60 min
of incubation with 50 µM LY 294002 or 10 µM Akti-1/2 significantly increased HSP27
phosphorylation (Fig. 6A). Both basal and CCh-stimulated phosphorylation were affected by
LY 294002 while Akti-1/2 stimulated only basal phosphorylation. Rapamycin, which acts
on mTORC1 downstream of Akt, had no stimulatory effect on basal HSP27 phosphorylation
and produced only a small, insignificant reduction in CCh-stimulated phosphorylation. The
activity of LY 294002, Akti-1/2 or rapamycin was confirmed by the inhibition of CChstimulated Akt or S6 ribosomal protein phosphorylation in cell lysates (Fig. 6B). Akt is a
downstream target of PI3-K while Akti-1/2 prevents a conformational change in Akt that
allows its phosphorylation by PDK1 and mTORC2 (Bain et al., 2007). The S6 ribosomal
protein is a substrate of mTORC1.
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These results being consistent with a relationship between Akt and HSP27, a more detailed
analysis of the effect of Akti-1/2 on HSP27 phosphorylation was performed (Fig. 6C).
Akti-1/2-mediated increases in HSP27 phosphorylation were blocked by simultaneous
incubation with SB 203580, implying an inverse relationship between Akt and p38 MAPK
activities. Support for this relationship was provided by increased phosphorylation of p38
MAPK at Thr-180/Tyr-182, a site that determines p38 MAPK activity, in cell lysates
prepared from cells following incubation with Akti-1/2 (Fig. 6D). Under the same
conditions, CCh produced only a small, insignificant increase in p38 MAPK
phosphorylation, consistent with the relatively small effect of the p38 MAPK inhibitor, SB
203580, on HSP27 phosphorylation at Ser-82 (Fig. 3A). When Akti-1/2 was combined with
GF 109203X, phosphorylation was not different from that produced by preincubation with
Akti-1/2 alone (Fig. 6C). Since the combination of SB 203580, GF 109203X and Akti-1/2
reduced HSP27 phosphorylation to basal levels ± CCh, muscarinic receptor-mediated
phosphorylation of HSP27 at Ser-82 can be totally accounted for by PKC, p38MAPK and
Akt. These results also demonstrate that the degree to which Ser-82 in HSP27 is
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phosphorylated by p38 MAPK after muscarinic receptor activation can be modulated
through the PI3-K pathway, presumably by interactions of p38 MAPK with Akt.
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3.5 HSP27 phosphorylation in differentiated SH-SY5Y cells
Even though the SH-SY5Y cell line is commonly taken to be a model for neurons, there are
inherent limitations in using an undifferentiated neuroblastoma to examine neuronal
processes. To increase the physiological relevance of this study, it was determined whether
differentiated SH-SY5Y cells respond to the three modulators that increase HSP27
phosphorylation in undifferentiated cells: CCh, PDB and Akti-1/2. To achieve this, SHSY5Y cells were differentiated in serum-free medium containing a low concentration of
PDB and a growth factor, in this case, bFGF. These conditions produce a mature neuronal
phenotype including expression of specific protein markers, catecholaminergic properties
and elaboration of a network of processes with varicosities and growth cones (Lavenius et
al, 1994; Pahlman et al, 1995).
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After 5 days of culture in serum-free medium containing 16 nM PDB and 3 nM bFGF, SHSY5Y cells display much longer processes than undifferentiated cells grown for 2 days in
DMEM with 10% FBS, the standard conditions used to analyze HSP27 phosphorylation
(Fig. 7A and B). Cells cultured for the same time in serum-free medium alone resemble the
latter with the short, pointed processes characteristic of SH-SY5Y cells. (data not shown).
As described in the original report of the differentiation protocol (Lavenius et al, 1994),
some of the processes contain varicosities and terminate in growth-cone-like structures.
Following differentiation, SH-SY5Y cells respond acutely to 1 µM PDB with a GF
109203X–sensitive phosphorylation of HSP27 that is comparable to that seen in
undifferentiated cells, indicating that PKC has not been down-regulated during the 5 day
exposure to nM concentrations of PDB (Fig. 7C). Increased phosphorylation of HSP27 also
occurs in differentiated cells in response to CCh or Akti-1/2. The magnitude of these effects
appears to be less than obtained in the undifferentiated cells, however, the pharmacological
sensitivity of the CCh-mediated increase to hyoscyamine demonstrates that muscarinic
receptors are still coupled to HSP27 phosphorylation in differentiated cells. In addition,
reversal of Akti-1/2-mediated HSP27 phosphorylation by SB 203580 replicates the inverse
relationship between Akt and p38 MAPK that is seen in undifferentiated cells (Fig. 7C).
3.6 lmmunolocalization of phosphorylated HSP27 and f-actin in response to CCh and PDB
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Phosphorylation of HSP27 is functionally associated with remodeling of the actin
cytoskeleton and alterations in cell morphology (Gusev, et al., 2002; Mounier and Arrigo,
2002; During et al., 2007), both of which are also modulated in SH-SY5Y cells by
muscarinic receptor activation or exposure to a phorbol ester (Rösner et al., 1995; Danks et
al., 1999). Given the different pathways leading to phosphorylation of HSP27 in response to
CCh-mediated muscarinic receptor activation and the phorbol ester, PDB, phase contrast
microscopy and immunofluorescence microscopy were used to compare changes in the
organization of the actin-based cytoskeleton that occur when HSP27 phosphorylation at
Ser-82 is modulated in (undifferentiated) SH-SY5Y cells by either stimulus. In control cells,
phospho-HSP27 immunolabeling had a finely dispersed, speckled distribution (Fig. 8A).
When preimmuune rabbit IgG was substituted for a primary antibody directed against
phospho-HSP27, little to no immunostaining was observed (data not shown). Following
stimulation of muscarinic receptors with 1 mM CCh for 5 min, phospho-HSP27 (Ser-82)
immunostaining became generally more intense but with a dispersed, punctuate or
reticulated appearance at the cell margins and denser perinuclear immunostaining (Fig. 8D).
Similar changes in phospho-HSP27 level and distribution occurred when cells were
stimulated for 15 min with 1 µM PDB (Fig. 8G). Thus, although CCh and PDB stimulate
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phosphorylation of Ser-82 in HSP27 through different combinations of protein kinases, the
pattern of immunostaining in response to either stimulus is comparable.
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In control cells, f-actin, as visualized with rhodamine-phalloidin, was principally seen as
fibers but with some intense spots that may be focal adhesions (Fig. 8B). Exposure to 1 mM
CCh for 5 min produced a modest increase in actin filaments associated with some
broadening of the short cell processes (Fig. 8E). In contrast, 15 min of stimulation with 1
µM PDB caused extensive re-organization of the f-actin cytoskeleton into arrays of
filaments at the margins of elaborate lamellipodial processes (Fig. 8H). Overlay of labeled factin and phospho-HSP27 images demonstrates segregation of these two proteins at such
PDB-induced sites (Fig 8I) in comparison to either the control or CCh condition (Fig. 8C
and F). The differences in CCh- and PDB-induced HSP27 immunfluorescence relative to the
actin cytoskeleton at cell processes are most readily observed in microscopic fields
containing a single cell as in the representative double-labeled examples shown in the lower
panel of Fig. 8.

NIH-PA Author Manuscript

Since the phosphorylation of HSP27 in response to PDB can be attributed to the activation
of a single protein kinase pathway (PKC to PKD), this stimulus was chosen to examine
morphological changes that may reflect interaction between phosphorylated HSP27 and factin. The morphology of undifferentiated cells was examined after 15 min or 2 hr of
exposure to PDB. In the latter case, the concentration of PDB was reduced from 1 µM to 10
nM to avoid down-regulation of PKC over the longer time period. Immunoblotting
following 2 hr of exposure of cells to 10 nM PDB confirmed that HSP27 is phosphorylated
at Ser-82 to an equal extent as obtained with 1 µM PDB for 15 min (data not shown). The
more acute set of conditions was chosen to correspond to those used to produce rapid
changes in HSP27 phosphorylation. The second allowed assessment of the duration of
morphological effects in relation to HSP27 phosphorylation since 10 nM PDB induces
changes in SH-SY5Y cell morphology starting at 10 min of exposure that are maintained for
up to 24 hr (Rösner et al., 1995).
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Acute treatment with 1 µM PDB for 15 min caused rapid elaboration of lamellipodial
processes at the ends of the short, pointed processes normally observed on cells and
extensive remodeling at the cell margins (Figs. 9A–C). These changes were persistent as
identical cellular phenotypes were observed after exposure of cells to 10 nM PDB for 2 hr
(Figs. 9D–F). Involvement of PKC was demonstrated through blockade of the
morphological change by preincubation of cells with 5 µM GF 109203X prior to addition of
PDB. In contrast to the lamellipodial profile of PDB-treated cells, GF 109203X, either alone
or in combination with PDB treatment, caused elongation and secondary branching of
filopodial processes (Fig. 10A; Compare Figs. 10B and C). Thus, inhibition and stimulation
of PKC have opposing effects on SH-SY5Y cell morphology.
To obtain a more quantitative measure of the morphology changes and to compare the
effects of PKC or PKD inhibition on formation of lamellipodia, cells were incubated with
PDB following preincubation with or without GF 109203X or CID 755673 after which
fields of cells were counted for the presence of flared lamellipodia. The results of this
analysis are shown in Table II. In response to PDB, approximately 45% of the cells in any
one field have flared lamellipodia. This phenotype was rarely observed in control cells or in
the presence of either protein kinase inhibitor alone. Preincubation of cells with GF
109203X completely blocked the reorganization into lamellipodial profiles by PDB. In
contrast, inhibition of PKD with CID 755673 was without effect on PDB-induced
lamellipodia.
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4. Discussion
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HSP27 acts to protect cells, including neurons, from injurious stimuli, whether it is
constitutively expressed (Lewis et al., 1999) or following induction by heat shock or
experimental manipulations (Akbar et al., 2003; Dodge et al., 2006; Sharp et al., 2008). This
overall function occurs in a pleiotropic manner through inhibition of apoptosis, chaperoning
of misfolded proteins, activation of the proteasome and stabilization of the actin
cytoskeleton (Arrigo, 2007). The chaperone function of HSP27 is mediated by its
dephosphorylated oligomeric form (Lambert et al., 1999; Rogalla et al., 1999) while
phosphorylation-dependent disassociation of HSP27 oligomers is required to block
apoptosis (Gusev et al., 2002; Benn and Woolf, 2004). Moreover, the way in which HSP27
interacts with actin differs based on its phosphorylation state (Mounier and Arrigo, 2002).
Therefore, it is of interest to characterize mechanisms that regulate the multiple protein
kinases that phosphorylate HSP27.
4.1 Significance of muscarinic receptor-mediated phosphorylation of HSP27
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HSP27 is documented in the literature as a neuroprotective protein, promoting survival and
chaperoning proteins that aggregate in neurodegenerative states (Benn and Woolf, 2004;
Klettner, 2004; Latchman, 2005; Koren et al., 2009). Since HSP27 phosphorylation is an
obligate determinant of its functions, it is desirable to stimulate this posttranslational
modification without resorting to stressful conditions such as heat shock or exposure to toxic
agents. This first characterization of HSP27 phosphorylation in response to muscarinic
receptor activation in a cell with a neuron-like phenotype suggests that synaptic cholinergic
receptor-mediated signaling could provide a means to do so given adequate expression of
HSP27.
Most neurons do not contain appreciable levels of HSP27 under basal conditions, sensory
neurons and limited populations in the CNS being notable exceptions. However, in response
to insult or pathology, neuronal HSP27 expression is up-regulated in a more generalized
way (Akbar et al., 2001; 2003). Thus, under conditions when activation of the functions of
HSP27 would be most beneficial, muscarinic receptor-mediated phosphorylation might be
an effective means to achieve this. SH-SY5Y cells differentiated with a phorbol ester and
growth factor are phenotypically similar to dopaminergic neurons and have the potential to
model aspects of the neurochemistry of Parkinson’s disease (Reviewed by Xie et al, 2010).
Such differentiated cells retain cholinergic receptors (Pahlman et al., 1995) and our
observation that they respond to CCh with increased HSP27 phosphorylation in a
hyoscyamine-sensitive manner indicates their potential to test the hypothesis that muscarinic
receptor-mediated phosphorylation serves an adaptive purpose in neurons.
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4.2 PKC Signaling and HSP27 phosphorylation
Given activation of phospholipase Cβ by Gq/11-coupled muscarinic receptors, it would be
expected that CCh binding to the M3 receptor increases PKC activity through generation of
1, 2-diacylglycerol. Indeed, in SH-SY5Y cells, CCh-stimulated HSP27 phosphorylation is
partially sensitive to GF 109203X, an inhibitor of PKC, while direct stimulation of PKC
with a phorbol ester produces significant phosphorylation of HSP27 at Ser-82. Recently,
PKD, a member of the calcium/calmodulin-dependent protein kinase family that is activated
by PKC-dependent phosphorylation, was demonstrated to be a HSP27 kinase in pancreatic
cancer cells (Yuan and Rozengurt, 2008). In this instance and others, p38 MAPK-mediated
phosphorylation of HSP27 was also secondary to PKC activation (Nomura et al., 2007; Guo
et al., 2008). However, the inability of a p38 MAPK inhibitor to affect phorbol esterstimulated HSP27 phosphorylation eliminates this possibility in SH-SY5Y cells.
Conversely, the complete reduction of HSP27 phosphorylation produced by inhibitors of
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either PKC or PKD indicates that all of the phosphorylation of HSP27 that is induced by a
phorbol ester occurs through this pathway.
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Activation of PKC by PDB is a more selective stimulus than muscarinic receptor activation
not only because the subsequent phosphorylation of HSP27 occurs through a single kinase
pathway, but also because only one of the three phosphorylation sites in HSP27 (Ser-82) is
modified. In contrast, CCh increases phosphorylation comparably at both Ser-78 and Ser-82.
The resultant double negative charge at two amino acids residues close to one another is
likely to uniquely determine interactions of HSP27, both with itself in oligomers and with
other proteins.
4.3 The PI3-K pathway and HSP27 phosphorylation
The combination of p38 MAPK and PKC inhibitors did not return CCh-stimulated HSP27
phosphorylation to basal levels indicating that there was another protein kinase involved.
The possibility that this was Akt was considered since there is an association between
HSP27 and Akt, both as a physical complex (Zheng et al. 2006) and in functional terms
during adaptation to stressors or NGF withdrawal (Konishi et al., 1997; Mearow et al.,
2002). Also, this study and others (Tang et al., 2002; Anger et al., 2007) have demonstrated
that Akt phosphorylation at Ser-473 increases when M3 muscarinic receptors are stimulated
with CCh.
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As a first approach to establish a relationship between the PI3-K pathway and HSP27
phosphorylation, SH-SY5Y cells were incubated with inhibitors of three sequential protein
kinases in this pathway, PI3-K, Akt and mTORC1. Unexpectedly, inhibition of either PI3-K
or Akt stimulated basal phosphorylation of HSP27 and the PI3-K inhibitor, LY 294002, also
increased CCh-mediated stimulation of HSP27 phosphorylation. An inverse relationship
between the PI3-K and p38 MAPK pathways accounted for this effect since 1.)
simultaneous incubation of Akti-1/2 and SB 203580 completely blocked such stimulation,
and 2.) the phosphorylation of p38 MAPK at Thr-180/Tyr-182, a marker of its activation,
was increased when Akt was inhibited.
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Phosphorylation of effector proteins by mTORC1 occurs following M3 receptor activation;
notably, mTORC1-mediated S6 phosphorylation is stimulated by CCh in SK-N-SH
neuroblastoma cells without a change in Akt phosphorylation (Slack and Blusztajn, 2008).
Therefore, the possibility that HSP27 might be a substrate of mTORC1 was addressed
through use of the selective inhibitor of this protein kinase, rapamycin. Rapamycin produced
no stimulation of basal HSP27 phosphorylation and did not affect CCh-stimulated
phosphorylation. Thus, the focal point for reciprocal regulation of PI3-K and p38 MAPK in
SH-SY5Y cells appears to be at the level of Akt.
The p38MAPK pathway is primarily involved in stress-activated phosphorylation of HSP27
(Rouse et al., 1994). It is not directly coupled to muscarinic receptors in SH-SY5Y cells
since the selective p38 MAPK inhibitor, SB 203580, has only a small partial effect on CChstimulated phosphorylation of Ser-82 in HSP27. However, the inverse relationship that
exists between Akt and p38 MAPK (i.e., p38 MAPK activity fully accounts for HSP27
phosphorylation at Ser-82 when Akt is inhibited) is consistent with a role in stress-activated
signaling. Because Akt is involved in survival pathways in neuroblastoma (Li and Thiele,
2007), its inhibition could represent a stressor that switches HSP27 phosphorylation to p38
MAPK as an adaptive response.
4.4 HSP27 phosphorylation in relation to cytoskeletal organization
Phosphorylation of HSP27 is linked to alterations in the actin-based cytoskeleton within
several contexts. Resistance to heat shock is dependent upon HSP27 phosphorylation with
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resultant cytoskeletal stability (Lavoie et al., 1995; Geum et al., 2002). Interaction of
phosphorylated HSP27 with the actin cytoskeleton is not strictly a correlate of the stressed
state, however, as it also mediates mitogenic stimulation and cell motility (Lavoie et al.,
1993; Nomura et al., 2007). Such an association has pathological relevance since anthrax
lethal toxin paralyzes neutrophils, which are responsible for innate immunity, by blocking
HSP27 phosphorylation and actin-based motility (During et al., 2007). Muscarinic receptor
activation and phorbol ester induce a phenotype in SH-SY5Y cells that includes formation
of lamellipodial protrusions and movement of dense-cored vesicles to the plasma membrane
for secretion of catecholamine, processes that require reorganization of the actin
cytoskeleton (Rösner et al., 1995; Viviani et al., 1996; Danks et al., 1999).
For these reasons, we have investigated relationship(s) between HSP27 phosphorylation,
actin reorganization and morphology in SH-SY5Y cells. Both CCh and PDB similarly
increase phospho-HSP27 immunofluorescence and alter cellular distribution of
phosphorylated HSP27 in SH-SY5Y cells to a perinuclear localization that is typical of its
activated state. Stimulation of cells also produces regions near the cell margins where
phospho-HSP27 immunofluorescence becomes more dispersed or reticular in appearance.
We have emphasized the phorbol ester-induced HSP27 phosphorylation in relation to the
state of f-actin and resultant changes in cell morphology since it can be related completely to
the PKC/PKD pathway.
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Three aspects of our results indicate that PKC/PKD-mediated phosphorylation of HSP27 at
Ser-82 is not a major factor during actin reorganization in SH-SY5Y cells. Firstly, the
lamellipodia formation that results from actin reorganization in response to PDB is not
sensitive to inhibition of PKD although an inhibitor of PKC completely blocks it. This is in
opposition to HSP27 phosphorylation at Ser-82 that is entirely sensitive to inhibition of
either kinase. Secondly, in our system, phosphorylated HSP27 clearly segregates from the
actin filaments that form at lamellipodial margins in response to phorbol ester eliminating a
model in which phosphorylated monomers of HSP27 directly associate with filamentous
actin (Lavoie et el., 1995; Rogalla et al., 1999). It is possible that HSP27 more subtly
modulates actin reorganization through another mechanism. For example, dephosphorylated
HSP27 may be either a barbed end capping protein (Benndorf et al., 1994) or sequester free
G-actin monomers (During et al. 2007). In either case, actin polymerization would be
prohibited while phosphorylation of HSP27 would allow remodeling of the cytoskeleton to
proceed. However, PDB and CCh produce similar changes in phosphorylation and cellular
distribution of HSP27 while only the former strongly induces lamellipodial formation. This
argues against such models and implies that downstream targets of PKC other than PKD and
phospho(Ser-82)-HSP27 are more critical in this regard. Our results differ from what is
observed in glioblastoma cells, where phorbol ester-induced HSP27 phosphorylation
depends upon the p38 MAPK/MAPKAPK-2 pathway and phospho-HSP27 does co-localize
with f-actin (Nomura et al., 2007). Thus, the signal transduction mechanisms that regulate
HSP27 phosphorylation appear to be quite cell-specific, even among malignant cells that are
characterized by a high degree of motility and abundant expression of HSP27 (Calderwood
and Ciocca, 2008).
Finally, given that muscarinic receptor-mediated HSP27 phosphorylation is via multiple
protein kinases, functions other than PKC-mediated regulation of f-actin structure are likely
be of significance in SH-SY5Y cells. Given the rapid maximal increase in HSP27
phosphorylation that occurs in response to CCh, these are likely to be acute processes. One
possibility is catecholamine release which is stimulated by both muscarinic receptor
activation and phorbol ester over a short time course in these cells (Rösner et al., 1995;
Viviani et al., 1996; Danks et al., 1999).
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Akti-1/2

1,3-Dihydro-1-(1-((4-(6-phenyl-1H–imidazo[4,5-g]quinoxalin-7yl)phenyl)methyl)-4-piperidinyl)-2H–benzimidazol-2-one

bFGF2

Basic fibroblast growth factor

CCh

Carbamoylcholine chloride (carbachol)

CID 755673

2,3,4,5-Tetrahydro-7-hydroxy-1H–benzofuro[2,3-c]azepin-1-one

DAPI

4’,6-diamidino-2-phenylindole

DMEM

Dulbecco’s Modification of Eagle’s Medium

ERK

Extracellular stimulus-regulated protein kinase

FBS

Fetal bovine serum

GF 109203X

2-[1-(3-Dimethylaminopropyl)-1H–indol-3-yl]-3-(1H–indol-3-yl)maleimide

HSP27

Heat shock protein 27

IGF-1

Insulin-like growth factor-1

IgG

Immunoglobulin fraction G

LY 294002

2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one

MAPK

Mitogen-activated protein kinase

MAPKAPK-2

MAPK-activated protein kinase-2

PD 98059

2-Amino-3’-methoxyflavone

PDB

Phorbol-12, 13-dibutyrate

MKK

MAP kinase kinase

mTORC

Mammalian target of rapamycin complex

PI3-K

Phosphatidylinositol 3-kinase

PLB

Passive lysis buffer

PKC

Protein kinase C

PVDF

Polyvinylidene fluoride

SB 203580

4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H–
imidazole

SDS-PAGE

Sodium dodecylsulfate polyacrylamide gel electrophoresis
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Fig. 1. Carbachol Increases HSP27 Phosphorylation in SH-SY5Y Cells

(A.) SH-SY5Y cells were plated at a density of 8 × 105 cells per 60 mm plate and cultured
for 2 days when the media was replaced with serum-free DMEM. After a 60 min
preincubation, CCh (1 mM) or an equal volume of DMEM (Control, C) were added for 5
min. Portions of cell lysates containing equal amounts of protein were resolved with SDSPAGE and immunoblotting was performed for phospho-(Ser-82)- or total HSP27. The
immunoblotting results shown are from 3 cell plates at each condition. (B.) Cells were
incubated for the indicated times under control conditions (■ - ■) or with 1 mM CCh (● - ●).
(C.) Cells were incubated for 5 min with the indicated concentrations of CCh. In panels B.
and C., densitometric results from 3–8 experiments are shown as the mean ± SEM of the
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increase in HSP27 phosphorylation normalized to the amount of total HSP27 in each
sample.
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Fig. 2. Carbachol Activates Muscarinic Receptors to Increase HSP27 Phosphorylation in SHSY5Y Cells

(A.) Cells were incubated as described in Fig. 1 except that 1µM hyoscyamine (Hy) was
added to some plates 60 min prior to addition of CCh or serum-free DMEM (Control, C) for
5 min. Results shown are the mean ± SEM of the increase in normalized HSP27
phosphorylation at Ser-82 from 3–4 experiments. (B.) Cells were preincubated for 1 hr in
serum-free DMEM prior to addition of 1mM CCh or nicotine (Nic) or 10 −7 M bradykinin
(BK) for 1 or 5 min. The insert shows a single immunoblot of phospho-(Ser-82)- and total
HSP27. Results from 3–4 experiments were combined to obtain the mean ± SEM of the
normalized HSP27 phosphorylation. ** p< 0.01 as compared to the control value.
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Fig. 3. Phosphorylation of HSP27 is Sensitive to Multiple Stimuli in a Protein Kinase-Specific
Manner

(A.) SH-SY5Y cells were preincubated with inhibitors of p38 MAPK, SB 203580 (SB, 10
µM) and/or PKC, GF 109203X (GF, 5 µM) or an equal volume of the vehicle, DMSO.
Following addition of 1 mM CCh or an equal volume of DMEM (Control, C) for 5 min,
cells lysates were prepared. Samples containing equal amounts of protein were resolved with
SDS-PAGE prior to immunoblotting for phospho-(Ser-82)- or total HSP27. Results are
expressed as the mean ± SEM of normalized HSP27 phosphorylation from 4–8 experiments.
(B.) Cells were incubated in serum-free DMEM for 60 min with addition of 1 µM PDB
during the last 15 min prior to preparation of cell lysates. In different samples, the medium
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was changed at 30 min to include 0.3 M sorbitol (Sorb) to induce hyperosmotic conditions.
At this time, the serum-free DMEM on control (C) plates was also replaced. Where
indicated, protein kinase inhibitors (GF or SB) were present throughout the incubation.
Equal volumes of the DMSO vehicle for PDB and the protein kinase inhibitors were added
to control (C) plates. Immunoblotting results from 5 or 6 experiments of this type were
analyzed with densitometry to obtain the mean ± SEM of normalized HSP27
phosphorylation. ** p< 0.01 as compared to the control value; + p< 0.05 as compared to the
CCh value; ++ p< 0.01 as compared to the CCh value.
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Fig. 4. Comparison of HSP27 Phosphorylation in Response to Carbachol or Phorbol Ester

(A.) SH-SY5Y cells were incubated under control (C) conditions, with 1 mM CCh or with 1
µM PDB as described in Fig. 3. Portions of the cell lysates were resolved with SDS-PAGE
and immunoblotting was performed for HSP27 with phospho-specific antibodies directed
against Ser-15, Ser-78 and Ser-82 or an antibody to total HSP27. (B.) Immunoblotting
results from 4 experiments of this type were analyzed with densitometry to obtain the mean
± SEM of normalized HSP27 phosphorylation. (B.) SH-SY5Y cells were cultured and
preincubated with inhibitors of PKC [GF 109203X (GF, 5 µM)], p38 MAPK [SB 203580
(SB, 10 µM)] or PKD [CID 755673 (CID, 25 µM)] or an equal volume of the vehicle,
DMSO. Following incubation for 45 min, 1 µM PDB or an equal volume of DMSO
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(Control, C) were added for 15 min and cell lysates were prepared. Samples containing
equal amounts of protein were resolved with SDS-PAGE prior to immunoblotting for
phospho-(Ser-82)- or total HSP27. Results are expressed as the mean ± SEM of normalized
HSP27 phosphorylation from 4–6 experiments. ** p< 0.01 as compared to the control
value; ++ p< 0.01 as compared to the PDB value.
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Fig. 5. Muscarinic Receptor Activation Increases ERK1/2 and Akt Phosphorylation in SH-SY5Y
Cells

NIH-PA Author Manuscript

SH-SY5Y cells were cultured and incubated as described in Fig. 1. ± 1mM CCh. (A.)
Following lysis, cell samples containing equal amounts of protein were resolved with SDSPAGE and immunoblotting was performed for total and phosphorylated forms of ERK1/2
(Thr-202/Tyr-204) or Akt (Ser-473). Representative sets of immunoblots for each protein
are shown. (B.) Immunoblotting results from 3 (ERK1/2) or 5 (Akt) experiments of this type
were analyzed with densitometry to obtain the mean ± SEM of normalized phosphorylation.
Since similar results were obtained for ERK1 and ERK2, only the former protein was used
for densitometric analysis. (C.) Cells were preincubated with a MKK inhibitor, PD 98059
(PD, 10 µM) for 60 min or an equal volume of serum-free DMEM (Control, C) prior to
addition of 1mM CCh for 5 min. HSP27 phosphorylation at Ser-82 and total HSP27 were
determined with immunoblotting. Densitometric results are expressed as the mean ± SEM of
the increase in normalized HSP27 phosphorylation from 4–8 experiments of this type. * p<
0.05 as compared to the control value; ** p< 0.01 as compared to the control value.
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Fig. 6. Phosphorylation of HSP27 is Modulated by Inhibition of PI3-K or Akt
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(A.) Cells were incubated ± LY 294002 (LY, 50 µM), Akti-1/2 (A, 10 µM) or rapamycin (R,
0.1 µM) for 60 min prior to addition of CCh for 5 min. Control incubations (C) contained
equal volumes of the vehicles for CCh and/or the inhibitors. (B.) To confirm the activities of
LY, A and R, cells were incubated ± these protein kinase inhibitors for 60 min prior to
addition of 1 mM CCh or a corresponding volume of serum-free DMEM for 5 min. Lysates
were prepared, resolved with SDS-PAGE and immunoblotting was performed for phospho(Ser-473)-Akt or phospho-(Ser-235/236)-S6 ribosomal protein. (C.) Cells were preincubated
with Akti-1/2 alone or in combination with SB 203580 (SB, 10 µM) and/or GF 109203X
(GF, 5 µM) for 60 min prior to addition of 1 mM CCh or an equal volume of serum-free
DMEM for 5 min. Immunoblotting was performed on cell lysates for phospho-(Ser-82)- and
total HSP27. (D.) SH-SY5Y cells were incubated under control (C) conditions or with 1 mM
CCh for 5 min following a 60 min preincubation or with 10 µM Akti-1/2 (A) for 60 min.
Cell lysates were prepared and immunoblotting was performed with a phospho-specific
antibody directed against Thr-180/Tyr-182 in the activation domain of p38 MAPK or with
an antibody that recognizes p38 MAPK independent of its phosphorylation state. The insert
is a representative blot showing amounts of phospho- and total p38 MAPK in one
experiment. Results shown are the mean ± SEM of normalized phosphorylation from 3–12
experiments. ** p< 0.01 as compared to the control value; +p< 0.05 as compared to the CCh
value; ++p< 0.01 as compared to the CCh value; oo p< 0.01 as compared to the Akti-1/2
value.
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Fig. 7. HSP27 Phosphorylation in Differentiated SH-SY5Y Cells

(A.) SH-SY5Y cells were grown under standard conditions (DMEM-10% FBS-penicilin/
streptomycin for 2 days. (B.) Twenty-four hr after plating of SH-SY5Y cells, the medium
was changed to serum-free DMEM containing 16 nM PDB and 3 nM bFGF. These
conditions were maintained for 5 days. Cells grown under both conditions were imaged with
phase contrast microscopy. (C.) Cells were differentiated, preincubated with hyoscyamine
(Hy, 1 µM), GF 109203X (GF, 5 µM), Akti-1/2 (A, 10 µM) ± SB 203580 (SB, 10 µM) or
DMSO vehicle. CCh (1 mM) or PDB (1 µM) were added for 5 min or the last 15 min of the
preincubation, respectively. Lysates were prepared, equal volumes of protein were resolved
with SDS-PAGE amd immunoblotting was performed for phospho-(Ser-82)-HSP27 or total
HSP27. Normalized results were averaged (± SEM) from 3 experiments with CCh and
duplicate experiments under all other conditions.
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Fig. 8. Muscarinic Receptor Activation and Phorbol Ester Increase Phospho-HSP27
Immunofluorescence and Alter the Actin Cytoskeleton in SH-SY5Y Cells
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SH-SY5Y cells were cultured for 2 days post-plating on glass coverslips. The medium was
changed to serum-free DMEM 60 min prior to addition of CCh (D., E., F.) to a final
concentration of 1 mM for 5 min or 1 µM PDB (G., H., I.) for the last 15 min of the
preincubation. Control cells (A., B., C.) were incubated for the same times with an equal
volume of the corresponding vehicle (serum-free DMEM or DMSO). Cells were fixed,
permeabilized and immunolabeled for phospho-(Ser-82)-HSP27 [Green: (A. D., G)] and
stained for f-actin with rhodamine phalloidin [Red: B., E., H.)]. Cell nuclei were
counterstained with DAPI (Blue). Images were obtained at the same resolution and exposure
time and are representative of triplicate experiments with each concentration and time of
incubation with CCh or PDB. Bottom Panel: SH-SY5Y cells, grown on glass coverslips,
were incubated with CCh or PDB as described. The double labeled images shown were
selected to emphasize the distribution of phospho-(Ser-82)-HSP27 (Green) and f-actin (Red)
in individual cells.
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Fig. 9. Activation of PKC Changes SH-SY5Y Cell Morphology to a Lamellipodial Phenotype
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SH-SY5Y cells were grown on 60 mm polystyrene plates for two days. The medium was
replaced with serum-free DMEM and cells were preincubated for 60 min prior to addition of
PDB under two conditions: at a concentration of 1 µM for 15 min (B., C) or at 10 nM for 2
hr (E., F). Control cells were incubated for the same times with an equal volume of the
vehicle, DMSO (A., D.). Cell images were then obtained with phase contrast microscopy.
The images shown were selected as examples of the morphology typical of control cells or
those treated with each concentration of PDB from triplicate experiments.
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Fig. 10. The Effect of PDB on Cell Morphology is Long-lasting and Reversed by Inhibition of
PKC

(A.) Two days post-plating, SH-SY5Y cells were preincubated for 60 min ± 5 µM GF
109203X prior to addition of 10 nM PDB for 2 hr or with an equal volume of the vehicle,
DMSO (Control, C) for 2 hr. Cells were imaged with phase contrast microscopy. The single
cells shown in the boxed areas in (A.) were enlarged to show typical examples of the
morphology induced by PDB (B.) or GF 109203X (C.) in duplicate experiments.
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Selectivity of protein kinase inhibitorsa
Inhibitor

Protein Kinase

Concentration

References

SB 203580

α- and β-p38 MAPK

10 µM

Cuenda et al., 1995

GF 109203X

PKC

5 µM

Heikkilä et al. 1993

PD 98059

MKK

10 µM

Kim et al., 1997

LY 294002

PI3-K

50 µM

Vlahos et al., 1994

Akti-1/2

Akt1 and Akt2

10 µM

Barnett et al., 2005

Rapamycin

mTORC1

0.1 µM

Slack and Blusztjn, 2008

CID 755673

PKD

25 µM

Sharlow et al., 2008

a

The concentrations of protein kinase inhibitors were selected with reference to tabulated data of their target selectivities as determined by Davies
et al., 2000 and Bain et al., 2007. More specific information regarding concentrations that achieve effective inhibition of each targeted protein
kinase in cultured cells was obtained from the references shown in the Table. The full chemical name of each protein kinase inhibitor is provided in
the list of abbreviations.
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TABLE II

Effect of protein kinase inhibitors on phorbol ester-induced SH-SY5Y cell morphology
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Condition

% Cells with Flared Lamellipodia

Control

1.5 ± 0.8

GF 109203X

0.5 ± 0.2

PDB

43.0 ± 1.5

PDB + GF 109203X

1.5 ± 0.8

Control

1.0 ± 0.9

CID 755673

0±0

PDB

46 ± 2.8

PDB + CID 755673

47.0 ± 3.0

SH-SY5Y cells were cultured at a density of 4 × 105/60 mm plate. Two days after plating, the medium was changed to serum-free DMEM with
addition of protein kinase inhibitors for 1 hr at concentrations shown in Table 1. Control plates contained an equal volume of DMSO. Phorbol ester
(PDB) was then added for 2 hr at a concentration of 10 nM. Cells were imaged with phase contrast microscopy. For each condition, 50 cells per
field were counted for the presence of flared lamellipodia (as shown in Figs. 9 and 10). The results are the average ± SEM from a total of 4 fields
from duplicate experiments with each protein kinase inhibitor.
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